US Calls OxyContin FCA Suit 'Parasitic'
The federal government asked the Fourth Circuit on Wednesday to dismiss a qui tam lawsuit accusing Purdue Pharma LP of falsely marketing painkiller OxyContin, arguing it was a "parasitic follow-on lawsuit"...To view the full article, register now.
Already a subscriber? Click here to view full article